相关实验视频

Updated: Jun 8, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

癌症中的铁亡:对T细胞的新视角

Yuping Lai¹, Chunxia Huang², Jiaqiang Wu³

¹Department of Gastroenterological Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; The Huankui academy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.

International immunopharmacology

|November 2, 2024

概括

本综述探讨了T细胞和癌症中细胞死亡过程铁亡之间的联系. 了解这种联系可以帮助开发新的癌症免疫疗法,通过向铁亡来提高T细胞活性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞死亡研究细胞死亡研究

背景情况:

T细胞对抗癌症免疫非常重要,但在瘤微环境中经常被抑制.
铁亡,一个依赖于铁和活性氧物种的受调细胞死亡途径,越来越多地被认为是癌症中的作用.

研究的目的:

审查T细胞和癌症中的铁亡之间的复杂相互作用.
为了阐明这种交叉通话背后的分子机制.
探索针对铁质的治疗策略,以提高T细胞介导的癌症免疫疗法.

主要方法:

关于T细胞,铁亡和癌症的最新科学发现的文献综述.
分析调节T细胞和铁亡之间的相互作用的分子机制.
在癌症免疫疗法中向铁亡的治疗含义的探索.

主要成果:

铁生可以调节瘤微环境中的T细胞功能和生存.
T细胞和免疫疗法可以通过调节癌细胞中的铁亡来影响癌症的进展.
T细胞和铁灭症之间的复杂交叉交互提供了新的治疗机会.

结论:

T细胞和铁亡之间的相互作用是癌症免疫力和进展的关键因素.
向铁亡具有显著的治疗潜力,可以增强T细胞驱动的抗癌反应.
进一步了解这种关系可能会导致创新的癌症免疫疗法.

关键词:

癌症癌症癌症癌症铁化是铁化的一种.免疫治疗是一种免疫疗法.在T细胞,T细胞.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...